Changing strategies for organ transplantation in atypical haemolytic uraemic syndrome: A tertiary case series

Pediatric Transplantation

Volumn 17, Issue 3, 2013, Pages

  Forbes, Thomas A ^a   Bradbury, Mark G ^b   Goodship, Tim H J ^c   McKiernan, Patrick J ^a   Milford, David V ^a  

^a BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^b ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

atypical haemolytic uraemic syndrome; chronic; complement factor H; eculizumab; kidney transplantation; liver transplantation; paediatric; renal insufficiency

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; AZATHIOPRINE; BASILIXIMAB; CAPTOPRIL; COMPLEMENT FACTOR H; DACLIZUMAB; DIPYRIDAMOLE; FRESH FROZEN PLASMA; HEPARIN; HYDROCORTISONE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; PREDNISOLONE; TACROLIMUS;

ANGIOPLASTY; ANTICOAGULANT THERAPY; ANTIHYPERTENSIVE THERAPY; ARTICLE; CASE REPORT; CASE STUDY; CATHETER INFECTION; CFH GENE; CHILD; CONGESTIVE HEART FAILURE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; FEMALE; GENE; GENE MUTATION; GENETIC ANALYSIS; HEMODIALYSIS; HEMOLYTIC UREMIC SYNDROME; HUMAN; HUMAN TISSUE; HYPERTENSION; HYPERTENSION ENCEPHALOPATHY; HYPOTENSION; IMMUNOSUPPRESSIVE TREATMENT; INFANT; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVER FUNCTION; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LOW DRUG DOSE; MALE; MEDICAL DECISION MAKING; NEPHRECTOMY; ORGAN TRANSPLANTATION; OUTCOME ASSESSMENT; PERITONEAL DIALYSIS; PLASMAPHERESIS; SCHOOL CHILD; SUPERIOR CAVA VEIN OBSTRUCTION; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ANTIBODIES, MONOCLONAL, HUMANIZED; ANTICOAGULANTS; CHILD; CHILD, PRESCHOOL; COMPLEMENT FACTOR H; FEMALE; HEMOLYTIC-UREMIC SYNDROME; HUMANS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; PLASMA EXCHANGE; QUALITY OF LIFE; RENAL INSUFFICIENCY; RISK; TREATMENT OUTCOME;

EID: 84876741397     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/petr.12066     Document Type: Article

References (29)

1. Kavanagh D, Goodship T,. Genetics and complement in atypical HUS. Pediatr Nephrol 2010: 25: 2431-2442.
2. Sellier-Leclerc A-L, Fremeaux-Bacchi V, Dragon-Durey M-A, et al. Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome. J Am Soc Nephrol 2007: 18: 2392-2400.
3. Loirat C, Fremeaux-Bacchi V,. Hemolytic uremic syndrome recurrence after renal transplantation. Pediatr Transplant 2008: 12: 619-629.
4. Saland JM, Ruggenenti P, Remuzzi G,. Liver-kidney transplantation to cure atypical hemolytic uremic syndrome. J Am Soc Nephrol 2009: 20: 940-949.
5. Despriet DDG, Klaver CCW, Witteman JCM, et al. Complement Factor H Polymorphism, Complement Activators, and Risk of Age-Related Macular Degeneration. JAMA 2006: 296: 301-309.
6. Larakeb A, Leroy S, Frémeaux-Bacchi V, et al. Ocular involvement in hemolytic uremic syndrome due to factor H deficiency-are there therapeutic consequences? Pediatr Nephrol 2007: 22: 1967-1970.
7. Haller W, Milford DV, Goodship THJ, Sharif K, Mirza DF, McKiernan PJ,. Successful isolated liver transplantation in a child with atypical hemolytic uremic syndrome and a mutation in complement factor H. Am J Transplant 2010: 10: 2142-2147.
8. Warwicker P, Goodship T, Donne R,. Genetic studies into inherited and sporadic hemolytic uremic syndrome. Kidney Int 1998: 53: 836-844.
9. Kavanagh D, Pappworth I, Roversi P, et al. Factor I autoantibodies are associated with atypical haemolytic uraemic syndrome. Mol Immunol 2010: 47: 2291-2292.
10. Seitz B, Albano L, Vocila F, et al. Recurrence of hemolytic uremic syndrome after renal transplantation. Transplant Proc 2007: 39: 2583-2585.
11. Loirat C, Niaudet P,. The risk of recurrence of hemolytic uremic syndrome after renal transplantation in children. Pediatr Nephrol 2003: 18: 1095-1101.
12. Bresin E, Daina E, Noris M, et al. Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: Prognostic significance of genetic background. Clin J Am Soc Nephrol 2006: 1: 88-99.
13. Richards A, Kathryn Liszewski M, Kavanagh D, et al. Implications of the initial mutations in membrane cofactor protein (MCP; CD46) leading to atypical hemolytic uremic syndrome. Mol Immunol 2007: 44: 111-122.
14. Fremeaux-Bacchi V, Moulton EA, Kavanagh D, et al. Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome. J Am Soc Nephrol 2006: 17: 2017-2025.
15. Richards A, Kemp E, Liszewski M,. Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome. Proc Natl Acad Sci USA 2003: 100: 12966-12971.
16. Cheong HI, Lee BS, Kang H-G, et al. Attempted treatment of factor H deficiency by liver transplantation. Pediatr Nephrol 2004: 19: 454-458.
17. Remuzzi G, Ruggenenti P, Codazzi D, et al. Combined kidney and liver transplantation for familial haemolytic uraemic syndrome. Lancet 2002: 359: 1671-1672.
18. Remuzzi G, Ruggenenti P, Colledan M, et al. Hemolytic uremic syndrome: A fatal outcome after kidney and liver transplantation performed to correct factor h gene mutation. Am J Transplant 2005: 5: 1146-1150.
19. Saland JM, Emre SH, Shneider BL, et al. Favorable long-term outcome after liver-kidney transplant for recurrent hemolytic uremic syndrome associated with a factor H mutation. Am J Transplant 2006: 6: 1948-1952.
20. Saland JM, Shneider BL, Bromberg JS, et al. Successful split liver-kidney transplant for factor H associated hemolytic uremic syndrome. Clin J Am Soc Nephrol 2009: 4: 201-206.
21. Jalanko H, Peltonen S, Koskinen A, et al. Successful liver-kidney transplantation in two children with aHUS caused by a mutation in complement factor H. Am J Transplant 2008: 8: 216-221.
22. Wilson C, Torpey N, Jaques B, et al. Successful simultaneous liver-kidney transplant in an adult with atypical hemolytic uremic syndrome associated with a mutation in complement factor H. Am J Kidney Dis 2011: 58: 109-112.
23. Alonzo A, Melgosa M, Lopez Trascasa M, Navarro M, Vega A, Corral Sanchez P,. Successful combined liver and kidney transplantation in a child with hypocomplementemic atypical haemolytic uremic syndrome (aHUS) due to a factor B mutation. Pediatr Nephrol 2011: 26: 1598.
24. Jokiranta TS, Zipfel PF, Fremeaux-Bacchi V, Taylor CM, Goodship TJH, Noris M,. Where next with atypical hemolytic uremic syndrome? Mol Immunol 2007: 44: 3889-3900.
25. Weitz M, Amon O, Bassler D, Koenigsrainer A, Nadalin S,. Prophylactic eculizumab prior to kidney transplantation for atypical hemolytic uremic syndrome. Pediatr Nephrol 2011: 26: 1325-1329.
26. Al-Akash SI, Almond PS, Savell VH, Gharaybeh SI, Hogue C,. Eculizumab induces long-term remission in recurrent post-transplant HUS associated with C3 gene mutation. Pediatr Nephrol 2011: 26: 613-619.
27. Zimmerhackl LB, Hofer J, Cortina G, et al. Prophylactic eculizumab after renal transplantation in atypical hemolytic-uremic syndrome. N Engl J Med 2010: 362: 1746-1748.
28. Zuber J, Quintrec ML, Krid S, et al. Eculizumab for Atypical Hemolytic Uremic Syndrome Recurrence in Renal Transplantation. Am J Transplant 2012: 12: 3337-3354.
29. Taylor CM, Machin S, Wigmore SJ, Goodship THJ,. Clinical practice guidelines for the management of atypical haemolytic uraemic syndrome in the United Kingdom. Br J Haematol 2010: 148: 37-47.